menu
    • menu

    Company profile for Adverum Biotechnologies

    NEW Drugs in Dev: 7
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Adverum is a clinical-stage gene therapy company targeting unmet medical need in ocular and rare diseases. We develop gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Our core capabilities include clinical development, novel vector discovery, and in-house manufacturing expertise, specifically in scalable process development, assay development, and c...
    Adverum is a clinical-stage gene therapy company targeting unmet medical need in ocular and rare diseases. We develop gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Our core capabilities include clinical development, novel vector discovery, and in-house manufacturing expertise, specifically in scalable process development, assay development, and current Good Manufacturing Practices (cGMP) quality control. Our team has extensive clinical development experience and is laser-focused on advancing novel gene therapies for patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Adverum BiotechnologiesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    800 Saginaw Drive, Redwood City, CA 94063
    Telephone
    Telephone
    650-656-9323
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://adverum.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/adverum-biotechnologies/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/adverumbio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lilly, Adverum Complete Tender Offer & Acquisition
    Lilly, Adverum Complete Tender Offer & Acquisition

    09 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lilly-and-adverum-announce-expiration-and-completion-of-adverum-tender-offer-and-acquisition-302636620.html

    PR NEWSWIRE
    09 Dec 2025
    Share Share
    Lilly Urges Adverum Shareholders To Tender Shares
    Lilly Urges Adverum Shareholders To Tender Shares

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3196864/32452/en/Adverum-Reminds-Stockholders-to-Tender-their-Shares-into-the-Offer-by-Lilly.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Eli Lilly Acquires Adverum, Expanding Into Eye Care Gene Therapy
    Eli Lilly Acquires Adverum, Expanding Into Eye Care Gene Therapy

    25 Oct 2025

    // REUTERS

    https://www.reuters.com/legal/transactional/eli-lilly-buy-gene-therapy-developer-adverum-about-262-million-deal-2025-10-24/

    REUTERS
    25 Oct 2025
    Share Share
    Adverum Biotech Completes Screening For Phase 3 Artemis Trial
    Adverum Biotech Completes Screening For Phase 3 Artemis Trial

    22 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/22/3153890/32452/en/Adverum-Biotechnologies-Announces-Completion-of-Screening-for-Pivotal-Phase-3-ARTEMIS-Trial-of-Ixo-vec-for-Wet-Age-Related-Macular-Degeneration.html

    GLOBENEWSWIRE
    22 Sep 2025
    Share Share
    Adverum Biotech Issues Inducement Grants per Nasdaq LR 5635(c)(4)
    Adverum Biotech Issues Inducement Grants per Nasdaq LR 5635(c)(4)

    05 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/05/3145476/32452/en/Adverum-Biotechnologies-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    05 Sep 2025
    Share Share
    Adverum Biotechnologies Q2 2025 Financial Results and Highlights
    Adverum Biotechnologies Q2 2025 Financial Results and Highlights

    12 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/12/3131551/32452/en/Adverum-Biotechnologies-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Pipeline-Highlights.html

    GLOBENEWSWIRE
    12 Aug 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search